1 Market Overview of Hemoglobinopathy 1.1 Hemoglobinopathy Market Overview 1.1.1 Hemoglobinopathy Product Scope 1.1.2 Market Status and Outlook 1.2 Global Hemoglobinopathy Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Hemoglobinopathy Market Size by Region (2015-2026) 1.4 Global Hemoglobinopathy Historic Market Size by Region (2015-2020) 1.5 Global Hemoglobinopathy Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Hemoglobinopathy Market Size YoY Growth (2015-2026) 1.6.1 North America Hemoglobinopathy Market Size YoY Growth (2015-2026) 1.6.2 Europe Hemoglobinopathy Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Hemoglobinopathy Market Size YoY Growth (2015-2026) 1.6.4 Latin America Hemoglobinopathy Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Hemoglobinopathy Market Size YoY Growth (2015-2026) 2 Hemoglobinopathy Market Overview by Type 2.1 Global Hemoglobinopathy Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Hemoglobinopathy Historic Market Size by Type (2015-2020) 2.3 Global Hemoglobinopathy Forecasted Market Size by Type (2021-2026) 2.4 Sickle cell disease 2.5 Alpha thalassemia 2.6 Beta thalassemia 3 Hemoglobinopathy Market Overview by Application 3.1 Global Hemoglobinopathy Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Hemoglobinopathy Historic Market Size by Application (2015-2020) 3.3 Global Hemoglobinopathy Forecasted Market Size by Application (2021-2026) 3.4 Hospitals 3.5 Diagnostic laboratories 3.6 Clinics 4 Global Hemoglobinopathy Competition Analysis by Players 4.1 Global Hemoglobinopathy Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy as of 2019) 4.3 Date of Key Manufacturers Enter into Hemoglobinopathy Market 4.4 Global Top Players Hemoglobinopathy Headquarters and Area Served 4.5 Key Players Hemoglobinopathy Product Solution and Service 4.6 Competitive Status 4.6.1 Hemoglobinopathy Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Abbott Diagnostics 5.1.1 Abbott Diagnostics Profile 5.1.2 Abbott Diagnostics Main Business 5.1.3 Abbott Diagnostics Products, Services and Solutions 5.1.4 Abbott Diagnostics Revenue (US$ Million) & (2015-2020) 5.1.5 Abbott Diagnostics Recent Developments 5.2 Bio-Rad Laboratories 5.2.1 Bio-Rad Laboratories Profile 5.2.2 Bio-Rad Laboratories Main Business and Company’s Total Revenue 5.2.3 Bio-Rad Laboratories Products, Services and Solutions 5.2.4 Bio-Rad Laboratories Revenue (US$ Million) (2015-2020) 5.2.5 Bio-Rad Laboratories Recent Development and Reaction to Covid-19 5.3 Danaher Corporation 5.5.1 Danaher Corporation Profile 5.3.2 Danaher Corporation Main Business 5.3.3 Danaher Corporation Products, Services and Solutions 5.3.4 Danaher Corporation Revenue (US$ Million) & (2015-2020) 5.3.5 Mindray Medical International Recent Developments 5.4 Mindray Medical International 5.4.1 Mindray Medical International Profile 5.4.2 Mindray Medical International Main Business 5.4.3 Mindray Medical International Products, Services and Solutions 5.4.4 Mindray Medical International Revenue (US$ Million) & (2015-2020) 5.4.5 Mindray Medical International Recent Developments 5.5 Nexcelom Bioscience 5.5.1 Nexcelom Bioscience Profile 5.5.2 Nexcelom Bioscience Main Business 5.5.3 Nexcelom Bioscience Products, Services and Solutions 5.5.4 Nexcelom Bioscience Revenue (US$ Million) & (2015-2020) 5.5.5 Nexcelom Bioscience Recent Developments 5.6 Nihon Kohden 5.6.1 Nihon Kohden Profile 5.6.2 Nihon Kohden Main Business 5.6.3 Nihon Kohden Products, Services and Solutions 5.6.4 Nihon Kohden Revenue (US$ Million) & (2015-2020) 5.6.5 Nihon Kohden Recent Developments 5.7 PerkinElmer 5.7.1 PerkinElmer Profile 5.7.2 PerkinElmer Main Business and Company’s Total Revenue 5.7.3 PerkinElmer Products, Services and Solutions 5.7.4 PerkinElmer Revenue (US$ Million) (2015-2020) 5.7.5 PerkinElmer Recent Development and Reaction to Covid-19 5.8 Siemens Healthineers 5.8.1 Siemens Healthineers Profile 5.8.2 Siemens Healthineers Main Business 5.8.3 Siemens Healthineers Products, Services and Solutions 5.8.4 Siemens Healthineers Revenue (US$ Million) & (2015-2020) 5.8.5 Siemens Healthineers Recent Developments 5.9 Sysmex Corporation 5.9.1 Sysmex Corporation Profile 5.9.2 Sysmex Corporation Main Business 5.9.3 Sysmex Corporation Products, Services and Solutions 5.9.4 Sysmex Corporation Revenue (US$ Million) & (2015-2020) 5.9.5 Sysmex Corporation Recent Developments 6 North America 6.1 North America Hemoglobinopathy Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Hemoglobinopathy Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Hemoglobinopathy Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Hemoglobinopathy Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Hemoglobinopathy Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Hemoglobinopathy Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Hemoglobinopathy Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Hemoglobinopathy Market Size by Region (2015-2020) (US$ Million) Table 3. Global Hemoglobinopathy Market Size Share by Region (2015-2020) Table 4. Global Hemoglobinopathy Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Hemoglobinopathy Forecasted Market Size Share by Region (2021-2026) Table 6. Global Hemoglobinopathy Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Hemoglobinopathy Market Size by Type (2015-2020) (US$ Million) Table 8. Global Hemoglobinopathy Revenue Market Share by Type (2015-2020) Table 9. Global Hemoglobinopathy Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Hemoglobinopathy Revenue Market Share by Type (2021-2026) Table 11. Global Hemoglobinopathy Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Hemoglobinopathy Market Size by Application (2015-2020) (US$ Million) Table 13. Global Hemoglobinopathy Revenue Market Share by Application (2015-2020) Table 14. Global Hemoglobinopathy Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Hemoglobinopathy Revenue Market Share by Application (2021-2026) Table 16. Global Hemoglobinopathy Revenue (US$ Million) by Players (2015-2020) Table 17. Global Hemoglobinopathy Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy as of 2019) Table 19. Date of Key Manufacturers Enter into Hemoglobinopathy Market Table 20. Global Hemoglobinopathy Top Players Headquarters and Area Served Table 21. Hemoglobinopathy Product Solution and Service Table 22. Global Hemoglobinopathy Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Abbott Diagnostics Basic Information List Table 25. Abbott Diagnostics Description and Business Overview Table 26. Abbott Diagnostics Hemoglobinopathy Products, Services and Solutions Table 27. Revenue (Million US$) in Hemoglobinopathy Business of Abbott Diagnostics (2015-2020) Table 28. Abbott Diagnostics Recent Developments Table 29. Bio-Rad Laboratories Basic Information List Table 30. Bio-Rad Laboratories Description and Business Overview Table 31. Bio-Rad Laboratories Hemoglobinopathy Products, Services and Solutions Table 32. Revenue (Million US$) in Hemoglobinopathy Business of Bio-Rad Laboratories (2015-2020) Table 33. Bio-Rad Laboratories Recent Developments Table 34. Danaher Corporation Basic Information List Table 35. Danaher Corporation Description and Business Overview Table 36. Danaher Corporation Hemoglobinopathy Products, Services and Solutions Table 37. Revenue (Million US$) in Hemoglobinopathy Business of Danaher Corporation (2015-2020) Table 38. Danaher Corporation Recent Developments Table 39. Mindray Medical International Basic Information List Table 40. Mindray Medical International Description and Business Overview Table 41. Mindray Medical International Hemoglobinopathy Products, Services and Solutions Table 42. Revenue (Million US$) in Hemoglobinopathy Business of Mindray Medical International (2015-2020) Table 43. Mindray Medical International Recent Developments Table 44. Nexcelom Bioscience Basic Information List Table 45. Nexcelom Bioscience Description and Business Overview Table 46. Nexcelom Bioscience Hemoglobinopathy Products, Services and Solutions Table 47. Revenue (Million US$) in Hemoglobinopathy Business of Nexcelom Bioscience (2015-2020) Table 48. Nexcelom Bioscience Recent Developments Table 49. Nihon Kohden Basic Information List Table 50. Nihon Kohden Description and Business Overview Table 51. Nihon Kohden Hemoglobinopathy Products, Services and Solutions Table 52. Revenue (Million US$) in Hemoglobinopathy Business of Nihon Kohden (2015-2020) Table 53. Nihon Kohden Recent Developments Table 54. PerkinElmer Basic Information List Table 55. PerkinElmer Description and Business Overview Table 56. PerkinElmer Hemoglobinopathy Products, Services and Solutions Table 57. Revenue (Million US$) in Hemoglobinopathy Business of PerkinElmer (2015-2020) Table 58. PerkinElmer Recent Developments Table 59. Siemens Healthineers Basic Information List Table 60. Siemens Healthineers Description and Business Overview Table 61. Siemens Healthineers Hemoglobinopathy Products, Services and Solutions Table 62. Revenue (Million US$) in Hemoglobinopathy Business of Siemens Healthineers (2015-2020) Table 63. Siemens Healthineers Recent Developments Table 64. Sysmex Corporation Basic Information List Table 65. Sysmex Corporation Description and Business Overview Table 66. Sysmex Corporation Hemoglobinopathy Products, Services and Solutions Table 67. Revenue (Million US$) in Hemoglobinopathy Business of Sysmex Corporation (2015-2020) Table 68. Sysmex Corporation Recent Developments Table 69. North America Hemoglobinopathy Market Size by Country (2015-2020) & (US$ Million) Table 70. North America Hemoglobinopathy Market Size Share by Country (2015-2020) Table 71. Europe Hemoglobinopathy Market Size by Country (2015-2020) & (US$ Million) Table 72. Europe Hemoglobinopathy Market Size Share by Country (2015-2020) Table 73. Asia-Pacific Hemoglobinopathy Market Size by Country (2015-2020) & (US$ Million) Table 74. Asia-Pacific Hemoglobinopathy Market Size Share by Country (2015-2020) (US$ Million) Table 75. Latin America Hemoglobinopathy Market Size by Country (2015-2020) & (US$ Million) Table 76. Latin America Hemoglobinopathy Market Size Share by Country (2015-2020) (US$ Million) Table 77. Middle East & Africa Hemoglobinopathy Market Size by Players (2015-2020) (US$ Million) Table 78. Middle East & Africa Hemoglobinopathy Market Size Share by Players (2015-2020) (US$ Million) Table 79. Hemoglobinopathy Market Trends Table 80. Hemoglobinopathy Market Drivers Table 81. Hemoglobinopathy Market Challenges Table 82. Hemoglobinopathy Market Restriants Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemoglobinopathy Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Hemoglobinopathy Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Hemoglobinopathy Market Share by Regions: 2020 VS 2026 Figure 4. North America Hemoglobinopathy Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Hemoglobinopathy Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Hemoglobinopathy Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Hemoglobinopathy Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Hemoglobinopathy Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Hemoglobinopathy Market Share by Type in 2020 & 2026 Figure 10. Sickle cell disease Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Alpha thalassemia Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Beta thalassemia Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Global Hemoglobinopathy Market Size Share by Application in 2020 & 2026 Figure 14. Hospitals Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Diagnostic laboratories Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Clinics Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Hemoglobinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Top 5 and Top 10 Players Hemoglobinopathy Market Share in 2019 Figure 19. United States Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Canada Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Germany Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. France Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. U.K. Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Italy Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Russia Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Nordic Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Rest of Europe Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Mexico Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Brazil Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Latin America Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Turkey Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Saudi Arabia Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. UAE Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Rest of Middle East & Africa Hemoglobinopathy Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation

Abbott Diagnostics Bio-Rad Laboratories Danaher Corporation Mindray Medical International Nexcelom Bioscience Nihon Kohden PerkinElmer Siemens Healthineers Sysmex Corporation